Clinical Trial

Development of an Inclusive Adaptive Treatment Strategy for Weight Loss in People With Prediabetes Using a Sequential Multiple Assignment Randomized Trial

Study acronym: iADAPT
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 8, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a sub-study to NCT04745572 to include a new cohort of participants with disabilities. This 16-week study will use an experimental approach called the Sequential Multiple Assignment Randomized Trial to help determine which combination and sequence of weight loss program features are most effective in people who are at risk for type 2 diabetes. Participants in the study will be initially randomized to consume either a high or reduced carbohydrate diet. After 4 weeks, participants will be identified as Responders (greater than or equal to 2.5% weight loss) or Non-Responders (less than 2.5% weight loss). Responders will continue with their initial randomized group for the remainder of the trial. Non-responders will be re-randomized to 2nd stage interventions of either including additional exercise counseling and training or beginning a time restricted eating protocol for the remainder of the trial.
Protocol Amendment History 3 changes
notable Primary completion pushed: 2026-07 -> 2026-07-31 2026-07-09
minor Completion pushed: 2026-07 -> 2026-07-31 2026-07-09
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-08
Trial Details
NCT Number NCT06976307
Lead Sponsor University of Alabama at Birmingham
Conditions Disabilities, Obesity and Overweight, Prediabetes
Enrollment 30 participants
Start Date 2026-03-24
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-08